Merck Stock-Based Compensation 2010-2025 | MRK

Merck stock-based compensation for the twelve months ending March 31, 2025 was $1.909B, a 18.35% increase year-over-year.

  • Merck annual stock-based compensation for 2024 was $0.761B, a 17.98% increase from 2023.
  • Merck annual stock-based compensation for 2023 was $0.645B, a 19.22% increase from 2022.
  • Merck annual stock-based compensation for 2022 was $0.541B, a 12.94% increase from 2021.

Merck Stock-Based Compensation 2010-2025 | MRK

  • Merck annual stock-based compensation for 2024 was $0.761B, a 17.98% increase from 2023.
  • Merck annual stock-based compensation for 2023 was $0.645B, a 19.22% increase from 2022.
  • Merck annual stock-based compensation for 2022 was $0.541B, a 12.94% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$749.3B
Johnson & Johnson (JNJ)$379.4B
AbbVie (ABBV)$344.4B
Novo Nordisk (NVO)$317.1B
Roche Holding AG (RHHBY)$262.9B
Novartis AG (NVS)$261.4B
Pfizer (PFE)$146.6B
Sanofi (SNY)$121B
Bayer (BAYRY)$31.9B
Innoviva (INVA)$1.2B